2019
DOI: 10.1109/tmbmc.2020.2979370
|View full text |Cite
|
Sign up to set email alerts
|

Abnormality Detection and Monitoring in Multi-Sensor Molecular Communication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 32 publications
0
10
0
Order By: Relevance
“…where (a) results from (4). By substituting the above equation in (5) and using some simplification, (5) can be reduced to the following form.…”
Section: A Decision Rulementioning
confidence: 99%
See 1 more Smart Citation
“…where (a) results from (4). By substituting the above equation in (5) and using some simplification, (5) can be reduced to the following form.…”
Section: A Decision Rulementioning
confidence: 99%
“…For example, the abnormality detection in medical applications has been received increasing attention in recent years [2]- [6]. The goal of these works is detecting the virus, bacteria, infectious micro organism or tumors in the body by means of static [2]- [4] or mobile nanomachines [5], [6]. If these abnormalities are detected, the next step would be treatments such as drug delivery, targeted therapy, nanosurgery, regenerative medicine and tissue engineering [7].…”
Section: Introductionmentioning
confidence: 99%
“…In the second type of targets, no molecule is released from the target and sensors release molecules after detecting abnormality [4], [5], [15]- [18]. Here, the sensors can follow one of these two scenarios: (i) they only detect and/or localize the abnormality [2], [15], [16]; (ii) they move to the target point to perform an action [4], [5], [17], [18]. In works on scenario (i), the goal is abnormality detection.…”
Section: A Related Workmentioning
confidence: 99%
“…Each sensor senses a part of tissue and cooperates with other sensors by sending molecules to a fusion center (FC) through a three dimensional (3-D) diffusion channel, if senses an abnormality. The focus of [16] is monitoring the abnormality propagation by determining the location and the time of the changes, using noncooperative fixed sensors releasing different molecules to the FC, where the channel model is the same as [15]. The scenario (ii) is applicable for targeted drug delivery [4], [5], [17], [18].…”
Section: A Related Workmentioning
confidence: 99%
See 1 more Smart Citation